Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis
- 1 June 1988
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 94 (6), 1383-1389
- https://doi.org/10.1016/0016-5085(88)90677-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Salicylates for the sulfa-sensitive patient with ulcerative colitis?Gastroenterology, 1986
- SulfasalazineDigestive Diseases and Sciences, 1983
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.Gut, 1980
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)Gut, 1973
- Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator PhenotypeNew England Journal of Medicine, 1973
- CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITISThe Lancet, 1965
- Controlled trial of sulphasalazine in the treatment of ulcerative colitisGut, 1964
- SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITISThe Lancet, 1962